Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society

Fertility and Sterility

Volumn 94, Issue 2, 2010, Pages 690-693

  Yildiz, Bulent O ^a   Azziz, Ricardo ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLYCOGEN SYNTHASE KINASE 3; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

ADIPOSE TISSUE; ANDROGEN SYNTHESIS; ARTICLE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; OBESITY; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADIPOSE TISSUE; FEMALE; HUMANS; HYPERANDROGENISM; OVARY; POLYCYSTIC OVARY SYNDROME;

EID: 77953707960     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.03.058     Document Type: Article

References (23)

1. Chang R.J. The reproductive phenotype in polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 3 (2007) 688-695
2. Franks S., Stark J., and Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 14 (2008) 367-378
3. Wickenheisser J.K., Nelson-DeGrave V.L., and McAllister J.M. Human ovarian theca cells in culture. Trends Endocrinol Metab 17 (2006) 65-71
4. Magoffin D.A. Ovarian enzyme activities in women with polycystic ovary syndrome. Fertil Steril 86 Suppl 1 (2006) S9-S11
5. Chang W., Goodarzi M.O., Williams H., Magoffin D.A., Pall M., and Azziz R. Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3. Fertil Steril 90 (2008) 2291-2297
6. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004) 2548-2556
7. Escobar-Morreale H.F., and San Millan J.L. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab 18 (2007) 266-272
8. Blouin K., Veilleux A., Luu-The V., and Tchernof A. Androgen metabolism in adipose tissue: recent advances. Mol Cell Endocrinol 301 (2009) 97-103
9. Abbott D.H., Barnett D.K., Bruns C.M., and Dumesic D.A. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?. Hum Reprod Update 11 (2005) 357-374
10. Ciaraldi T.P., Aroda V., Mudaliar S., Chang R.J., and Henry R.R. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. J Clin Endocrinol Metab 94 (2009) 157-163
11. Arner P. Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome. Biochimie 87 (2005) 39-43
12. Sverrisdottir Y.B., Mogren T., Kataoka J., Janson P.O., and Stener-Victorin E. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?. Am J Physiol Endocrinol Metab 294 (2008) E576-E581
13. Manneras L., Jonsdottir I.H., Holmang A., Lonn M., and Stener-Victorin E. Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome. Endocrinology 149 (2008) 3559-3568
14. Abbott D.H., Zhou R., Bird I.M., Dumesic D.A., and Conley A.J. Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome. Endocr Dev 13 (2008) 145-158
15. Abbott D.H., Barnett D.K., Levine J.E., Padmanabhan V., Dumesic D.A., Jacoris S., et al. Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol Reprod 79 (2008) 154-163
16. Ciaraldi T.P. Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity. J Pediatr Endocrinol Metab 13 Suppl 5 (2000) 1291-1293
17. Corbould A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol 192 (2007) 585-594
18. Corbould A. Effects of spironolactone on glucose transport and interleukin-6 secretion in adipose cells of women. Horm Metab Res 39 (2007) 915-918
19. Corton M., Botella-Carretero J.I., Benguria A., Villuendas G., Zaballos A., San Millan J.L., et al. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab 92 (2007) 328-337
20. Corton M., Botella-Carretero J.I., Lopez J.A., Camafeita E., San Millan J.L., Escobar-Morreale H.F., et al. Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum Reprod 23 (2008) 651-661
21. Carmina E., Bucchieri S., Esposito A., Del Puente A., Mansueto P., Orio F., et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 92 (2007) 2500-2505
22. Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo RA. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril. Published online May 1, 2008.
23. Tan B.K., Heutling D., Chen J., Farhatullah S., Adya R., Keay S.D., et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57 (2008) 1501-1507